Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis

Fingolimod is a selective immunosuppressive agent approved worldwide for the treatment of relapsing-remitting multiple sclerosis (MS), a chronic and potentially disabling neurological condition. Randomized double-blind clinical trials have shown that fingolimod significantly reduces relapse rate and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drug Healthc Patient Saf
Main Authors: Gajofatto, Alberto, Turatti, Marco, Monaco, Salvatore, Benedetti, Maria Donata
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4686225/
https://ncbi.nlm.nih.gov/pubmed/26715860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S69640
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki